Infectio nears market with Streptococcus B PCR (polymerase chain reaction) test
This article was originally published in Clinica
Executive Summary
Infectio Diagnostic, in partnership with US firm Cepheid, has filed a 510(k) marketing application with the US FDA for its rapid PCR-based screening test for Group B Streptococcus (GBS) in pregnant women at the time of delivery.